SCHEMBL4663541

SCHEMBL4663541

CN(C)CC1CC(Cc2ccc(Cl)cc2)CCC1(O)CCc1ccccc1

nearest known ligand 0.39

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.39
OPRM1 P35372 5/20 0.39
OPRL1 P41146 3/20 0.39
OPRK1 P41145 7/20 0.35
OPRD1 P41143 5/20 0.35
KDM1A O60341 1/20 0.35
RCOR1 Q9UKL0 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.34
ATP1A1 P05023 1/20 0.34
ATP1B1 P05026 1/20 0.34
ATP1A3 P13637 1/20 0.34
ATP1B2 P14415 1/20 0.34
ATP1A2 P50993 1/20 0.34
ATP1B3 P54709 1/20 0.34
FXYD2 P54710 1/20 0.34
ATP1A4 Q13733 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4663554 0.94 ALDH1A1 (0.38) ALDH1A1OPRM1OPRL1OPRK1OPRD1
SCHEMBL4665645 0.89 OPRM1 (0.39) OPRM1OPRL1OPRK1OPRD1KDM1A
SCHEMBL4663731 0.84 OPRM1 (0.36) ALDH1A1OPRM1OPRK1OPRD1SMN1; SMN2
SCHEMBL4665479 0.83 MEN1 (0.39) OPRM1OPRL1
SCHEMBL4665352 0.82 OPRM1 (0.35) ALDH1A1OPRM1OPRK1OPRD1SMN1; SMN2
SCHEMBL4663381 0.82 SMN1; SMN2 (0.41) ALDH1A1OPRM1OPRK1OPRD1SMN1; SMN2
SCHEMBL4663539 0.82 SLC6A4 (0.47) OPRM1OPRK1OPRD1
SCHEMBL4664046 0.81 SMN1; SMN2 (0.48) ALDH1A1OPRM1OPRK1OPRD1SMN1; SMN2
SCHEMBL4664186 0.81 CCR3 (0.43) ALDH1A1OPRM1OPRK1OPRD1SMN1; SMN2
SCHEMBL4664121 0.81 SLC6A4 (0.38) ALDH1A1OPRM1OPRL1OPRK1OPRD1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1571140-B1 C-substituted cyclohexylmethylamine derivatives GRUENENTHAL GMBH (DE) 2008-11-12 EP claimed
US-7273952-B2 Substituted C-cyclohexylmethylamine derivatives GRUENENTHAL GMBH (DE) 2007-09-25 US claimed
US-20030232891-A1 Substituted C-cyclohexylmethylamine derivatives GRUENENTHAL GMBH (DE) 2003-12-18 US claimed
EP-1571140-B1 C-substituted cyclohexylmethylamine derivatives GRUENENTHAL GMBH (DE) 2008-11-12 EP disclosed
US-7273952-B2 Substituted C-cyclohexylmethylamine derivatives GRUENENTHAL GMBH (DE) 2007-09-25 US disclosed
EP-1368299-B1 SUBSTITUTED C-CYCLOHEXYLMETHYLAMINE DERIVATIVES GRUENENTHAL GMBH (DE) 2006-07-26 EP disclosed
EP-1571140-A1 C-substituted cyclohexylmethylamine derivatives Grünenthal GmbH (DE) 2005-09-07 EP disclosed
US-20030232891-A1 Substituted C-cyclohexylmethylamine derivatives GRUENENTHAL GMBH (DE) 2003-12-18 US disclosed
EP-1368299-A2 SUBSTITUTED C-CYCLOHEXYLMETHYLAMINE DERIVATIVES Grünenthal GmbH (DE) 2003-12-10 EP disclosed
WO-2002030870-A2 SUBSTITUTED C-CYCLOHEXYLMETHYLAMINE DERIVATIVES Grünenthal GmbH (DE) 2002-04-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030232891-A1 Substituted C-cyclohexylmethylamine derivatives CNR2, CNR1, HNMT ALDH1A1 2922/4885OPRM1 5/4885OPRL1 9/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.